Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers says $2.1B Medarex acquisition passes mandatory review by antitrust regulators
Bristol-Myers says $2.1B Medarex acquisition passes mandatory review by antitrust regulators
Bristol-Myers says $2.1B Medarex acquisition passes mandatory review by antitrust regulators
Submitted by
admin
on August 12, 2009 - 4:28pm
Source:
Yahoo/AP
News Tags:
Medarex
M&A
Bristol-Myers Squibb
Headline:
Bristol-Myers says $2.1B Medarex acquisition passes mandatory review by antitrust regulators
Do Not Allow Advertisers to Use My Personal information
